MedTrace Logo

The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients

NCT05958069 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-07-24

No results posted yet for this study

Summary

Exploring the efficacy and safety of oral minocycline combined with antiepileptic drugs in the treatment of drug-resistant epilepsy in NORSE patients, obtaining preliminary research data, and providing evidence and data support for the next large-scale randomized controlled clinical study.

Conditions

  • Epileptic Seizures Related to Drugs

Interventions

DRUG

minocycline

Treatment with minocycline combined with antiepileptic drugs: After enrollment, 100mg/day (50mg specification) of minocycline hydrochloride was administered for 12 consecutive weeks;

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen jiang · The First Affiliated Hospital of Air Force Military Medical University

  • Lei Ma · The First Affiliated Hospital of Air Force Military Medical University

  • yuanyuan Wang · XijingHospital

  • mengmeng Hu · XijingHospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-03-01
Completion
2025-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05958069 on ClinicalTrials.gov